Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2D

REFERENCES

• Akkila, W. M., R. L. Chambers, O. I. Ornatsky, and J. C. McDermott. 1997. Molecular cloning of up-regulated cytoskeletal genes from regenerating skeletal muscle: potential role of myocyte enhancer factor 2 proteins in the activation of muscle-regeneration-associated genes. Biochem. J. 325:87–93.
   PubMedGoogle Scholar
• Amacher, S. L., J. N. Buskin, and S. D. Hauschka. 1993. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol. Cell. Biol. 13:2753–2764.
   PubMedGoogle Scholar
• Anderson, J. P., E. Dodou, A. B. Heidt, S. J. De Val, E. J. Jaehnig, S. B. Greene, E. N. Olson, and B. L. Black. 2004. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol. Cell. Biol. 24:3757–3768.
   PubMedGoogle Scholar
• Arnold, H. H., and B. Winter. 1998. Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. 8:539–544.
   PubMed Web of Science ®Google Scholar
• Belfield, J. L., C. Whittaker, M. Z. Cader, and S. Chawla. 2006. Differential effects of Ca2+ and cAMP on transcription mediated by MEF2D and cAMP-response element-binding protein in hippocampal neurons. J. Biol. Chem. 281:27724–27732.
   PubMedGoogle Scholar
• Berdeaux, R., N. Goebel, L. Banaszynski, H. Takemori, T. Wandless, G. D. Shelton, and M. Montminy. 2007. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat. Med. 13:597–603.
   PubMed Web of Science ®Google Scholar
• Black, B. L., and E. N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167–196.
   PubMed Web of Science ®Google Scholar
• Brand-Saberi, B. 2005. Genetic and epigenetic control of skeletal muscle development. Ann. Anat. 187:199–207.
   PubMed Web of Science ®Google Scholar
• Buckingham, M. 2006. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr. Opin. Genet. Dev. 16:525–532.
   PubMed Web of Science ®Google Scholar
• Buckingham, M. 2001. Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. 11:440–448.
   PubMed Web of Science ®Google Scholar
• Chen, A. E., D. D. Ginty, and C. M. Fan. 2005. Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433:317–322.
   PubMed Web of Science ®Google Scholar
• Cox, D. M., M. Du, X. Guo, K. W. Siu, and J. C. McDermott. 2002. Tandem affinity purification of protein complexes from mammalian cells. BioTechniques 33:267–270.
   PubMedGoogle Scholar
• Cox, D. M., M. Du, M. Marback, E. C. Yang, J. Chan, K. W. Siu, and J. C. McDermott. 2003. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J. Biol. Chem. 278:15297–15303.
   PubMedGoogle Scholar
• Creemers, E. E., L. B. Sutherland, J. McAnally, J. A. Richardson, and E. N. Olson. 2006. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 133:4245–4256.
   PubMed Web of Science ®Google Scholar
• Creemers, E. E., L. B. Sutherland, J. Oh, A. C. Barbosa, and E. N. Olson. 2006. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol. Cell 23:83–96.
   PubMed Web of Science ®Google Scholar
• Currie, P. D., and P. W. Ingham. 1998. The generation and interpretation of positional information within the vertebrate myotome. Mech. Dev. 73:3–21.
   PubMedGoogle Scholar
• de Angelis, L., J. Zhao, J. J. Andreucci, E. N. Olson, G. Cossu, and J. C. McDermott. 2005. Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev. Biol. 283:171–179.
   PubMed Web of Science ®Google Scholar
• Donoviel, D. B., M. A. Shield, J. N. Buskin, H. S. Haugen, C. H. Clegg, and S. D. Hauschka. 1996. Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol. Cell. Biol. 16:1649–1658.
   PubMed Web of Science ®Google Scholar
• Edmondson, D. G., G. E. Lyons, J. F. Martin, and E. N. Olson. 1994. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120:1251–1263.
   PubMed Web of Science ®Google Scholar
• Ewton, D. Z., and J. R. Florini. 1990. Effects of insulin-like growth factors and transforming growth factor-beta on the growth and differentiation of muscle cells in culture. Proc. Soc. Exp. Biol. Med. 194:76–80.
   PubMedGoogle Scholar
• Florini, J. R., D. Z. Ewton, and K. A. Magri. 1991. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 53:201–216.
   PubMed Web of Science ®Google Scholar
• Florini, J. R., D. Z. Ewton, K. A. Magri, and F. J. Mangiacapra. 1993. IGFs and muscle differentiation. Adv. Exp. Med. Biol. 343:319–326.
   PubMedGoogle Scholar
• Gong, X., X. Tang, M. Wiedmann, X. Wang, J. Peng, D. Zheng, L. A. Blair, J. Marshall, and Z. Mao. 2003. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38:33–46.
   PubMed Web of Science ®Google Scholar
• Grayson, J., R. Bassel-Duby, and R. S. Williams. 1998. Collaborative interactions between MEF-2 and Sp1 in muscle-specific gene regulation. J. Cell. Biochem. 70:366–375.
   PubMedGoogle Scholar
• Gregoire, S., and X. J. Yang. 2005. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol. 25:2273–2287.
   PubMed Web of Science ®Google Scholar
• Han, J., Y. Jiang, Z. Li, V. V. Kravchenko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296–299.
   PubMed Web of Science ®Google Scholar
• Hanson, M. G., Jr., S. Shen, A. P. Wiemelt, F. A. McMorris, and B. A. Barres. 1998. Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J. Neurosci. 18:7361–7371.
   PubMedGoogle Scholar
• Horikawa, M., S. Higashiyama, S. Nomura, Y. Kitamura, M. Ishikawa, and N. Taniguchi. 1999. Upregulation of endogenous heparin-binding EGF-like growth factor and its role as a survival factor in skeletal myotubes. FEBS Lett. 459:100–104.
   PubMedGoogle Scholar
• Husmann, I., L. Soulet, J. Gautron, I. Martelly, and D. Barritault. 1996. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev. 7:249–258.
   PubMedGoogle Scholar
• Jordan, M., A. Schallhorn, and F. M. Wurm. 1996. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24:596–601.
   PubMed Web of Science ®Google Scholar
• Kato, Y., V. V. Kravchenko, R. I. Tapping, J. Han, R. J. Ulevitch, and J. D. Lee. 1997. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16:7054–7066.
   PubMed Web of Science ®Google Scholar
• Lemercier, C., A. Verdel, B. Galloo, S. Curtet, M. P. Brocard, and S. Khochbin. 2000. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275:15594–15599.
   PubMed Web of Science ®Google Scholar
• Li, L., R. Heller-Harrison, M. Czech, and E. N. Olson. 1992. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol. Cell. Biol. 12:4478–4485.
   PubMedGoogle Scholar
• Li, M., X. Wang, M. K. Meintzer, T. Laessig, M. J. Birnbaum, and K. A. Heidenreich. 2000. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol. Cell. Biol. 20:9356–9363.
   PubMed Web of Science ®Google Scholar
• Lin, Q., J. Lu, H. Yanagisawa, R. Webb, G. E. Lyons, J. A. Richardson, and E. N. Olson. 1998. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125:4565–4574.
   PubMedGoogle Scholar
• Lin, Q., J. Schwarz, C. Bucana, and E. N. Olson. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404–1407.
   PubMed Web of Science ®Google Scholar
• Linseman, D. A., C. M. Bartley, S. S. Le, T. A. Laessig, R. J. Bouchard, M. K. Meintzer, M. Li, and K. A. Heidenreich. 2003. Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+)/calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J. Biol. Chem. 278:41472–41481.
   PubMed Web of Science ®Google Scholar
• Lu, J., T. A. McKinsey, C. L. Zhang, and E. N. Olson. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6:233–244.
   PubMed Web of Science ®Google Scholar
• Ludolph, D. C., and S. F. Konieczny. 1995. Transcription factor families: muscling in on the myogenic program. FASEB J. 9:1595–1604.
   PubMedGoogle Scholar
• Ma, K., J. K. Chan, G. Zhu, and Z. Wu. 2005. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol. Cell. Biol. 25:3575–3582.
   PubMed Web of Science ®Google Scholar
• Makarevich, A., A. Sirotkin, P. Chrenek, J. Bulla, and L. Hetenyi. 2000. The role of IGF-I, cAMP/protein kinase A and MAP-kinase in the control of steroid secretion, cyclic nucleotide production, granulosa cell proliferation and preimplantation embryo development in rabbits. J. Steroid Biochem. Mol. Biol. 73:123–133.
   PubMedGoogle Scholar
• Mao, Z., A. Bonni, F. Xia, M. Nadal-Vicens, and M. E. Greenberg. 1999. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785–790.
   PubMed Web of Science ®Google Scholar
• Mao, Z., and M. Wiedmann. 1999. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J. Biol. Chem. 274:31102–31107.
   PubMed Web of Science ®Google Scholar
• Martin, J. F., J. M. Miano, C. M. Hustad, N. G. Copeland, N. A. Jenkins, and E. N. Olson. 1994. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647–1656.
   PubMed Web of Science ®Google Scholar
• Miska, E. A., C. Karlsson, E. Langley, S. J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099–5107.
   PubMed Web of Science ®Google Scholar
• Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125–1136.
   PubMedGoogle Scholar
• Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1996. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16:2627–2636.
   PubMedGoogle Scholar
• Molkentin, J. D., L. Li, and E. N. Olson. 1996. Phosphorylation of the MADS-box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 271:17199–17204.
   PubMedGoogle Scholar
• Molkentin, J. D., and E. N. Olson. 1996. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93:9366–9373.
   PubMed Web of Science ®Google Scholar
• Morin, S., F. Charron, L. Robitaille, and M. Nemer. 2000. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19:2046–2055.
   PubMedGoogle Scholar
• Naya, F. J., and E. Olson. 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11:683–688.
   PubMed Web of Science ®Google Scholar
• Naya, F. J., C. Wu, J. A. Richardson, P. Overbeek, and E. N. Olson. 1999. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126:2045–2052.
   PubMedGoogle Scholar
• Okamoto, S., D. Krainc, K. Sherman, and S. A. Lipton. 2000. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl. Acad. Sci. USA 97:7561–7566.
   PubMed Web of Science ®Google Scholar
• Olson, E. N. 1990. MyoD family: a paradigm for development? Genes Dev. 4:1454–1461.
   PubMed Web of Science ®Google Scholar
• Ornatsky, O. I., J. J. Andreucci, and J. C. McDermott. 1997. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272:33271–33278.
   PubMedGoogle Scholar
• Ornatsky, O. I., D. M. Cox, P. Tangirala, J. J. Andreucci, Z. A. Quinn, J. L. Wrana, R. Prywes, Y. T. Yu, and J. C. McDermott. 1999. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res. 27:2646–2654.
   PubMed Web of Science ®Google Scholar
• Ornatsky, O. I., and J. C. McDermott. 1996. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells. J. Biol. Chem. 271:24927–24933.
   PubMedGoogle Scholar
• Ottens, A. K., F. H. Kobeissy, R. A. Wolper, W. E. Haskins, R. L. Hayes, N. D. Denslow, and K. K. Wang. 2005. A multidimensional differential proteomic platform using dual-phase ion-exchange chromatography-polyacrylamide gel electrophoresis/reversed-phase liquid chromatography tandem mass spectrometry. Anal. Chem. 77:4836–4845.
   PubMedGoogle Scholar
• Park, S. Y., H. M. Shin, and T. H. Han. 2002. Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter. Mol. Immunol. 39:25–30.
   PubMedGoogle Scholar
• Pearson, G. W., S. Earnest, and M. H. Cobb. 2006. Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals. Mol. Cell. Biol. 26:3039–3047.
   PubMedGoogle Scholar
• Pirskanen, A., J. C. Kiefer, and S. D. Hauschka. 2000. IGFs, insulin, Shh, bFGF, and TGF-beta1 interact synergistically to promote somite myogenesis in vitro. Dev. Biol. 224:189–203.
   PubMedGoogle Scholar
• Pownall, M. E., M. K. Gustafsson, and C. P. Emerson, Jr. 2002. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu. Rev. Cell Dev. Biol. 18:747–783.
   PubMed Web of Science ®Google Scholar
• Quinn, Z. A., C. C. Yang, J. L. Wrana, and J. C. McDermott. 2001. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res. 29:732–742.
   PubMedGoogle Scholar
• Rydel, R. E., and L. A. Greene. 1988. cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 85:1257–1261.
   PubMed Web of Science ®Google Scholar
• Sartorelli, V., J. Huang, Y. Hamamori, and L. Kedes. 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010–1026.
   PubMed Web of Science ®Google Scholar
• Seamon, K. B., and J. W. Daly. 1981. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7:201–224.
   PubMedGoogle Scholar
• Shore, P., and A. D. Sharrocks. 1995. The MADS-box family of transcription factors. Eur. J. Biochem. 229:1–13.
   PubMedGoogle Scholar
• Sirotkin, A. V., and R. Grossmann. 2006. The role of protein kinase A and cyclin-dependent (CDC2) kinase in the control of basal and IGF-II-induced proliferation and secretory activity of chicken ovarian cells. Anim. Reprod. Sci. 92:169–181.
   PubMedGoogle Scholar
• Sirotkin, A. V., P. Sanislo, H. J. Schaeffer, I. Florkovicova, J. Kotwica, J. Bulla, and L. Hetenyi. 2004. Thrombopoietin regulates proliferation, apoptosis, secretory activity and intracellular messengers in porcine ovarian follicular cells: involvement of protein kinase A. J. Endocrinol. 183:595–604.
   PubMed Web of Science ®Google Scholar
• Tajbakhsh, S., and G. Cossu. 1997. Establishing myogenic identity during somitogenesis. Curr. Opin. Genet. Dev. 7:634–641.
   PubMedGoogle Scholar
• Tollefsen, S. E., R. Lajara, R. H. McCusker, D. R. Clemmons, and P. Rotwein. 1989. Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J. Biol. Chem. 264:13810–13817.
   PubMed Web of Science ®Google Scholar
• Vivarelli, E., W. E. Brown, R. G. Whalen, and G. Cossu. 1988. The expression of slow myosin during mammalian somitogenesis and limb bud differentiation. J. Cell Biol. 107:2191–2197.
   PubMedGoogle Scholar
• Wang, X., X. Tang, M. Li, J. Marshall, and Z. Mao. 2005. Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival. J. Biol. Chem. 280:16705–16713.
   PubMed Web of Science ®Google Scholar
• Winter, B., T. Braun, and H. H. Arnold. 1993. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. J. Biol. Chem. 268:9869–9878.
   PubMedGoogle Scholar
• Yamane, A., M. L. Mayo, P. Bringas, Jr., L. Chen, M. Huynh, K. Thai, L. Shum, and H. C. Slavkin. 1997. TGF-alpha, EGF, and their cognate EGF receptor are co-expressed with desmin during embryonic, fetal, and neonatal myogenesis in mouse tongue development. Dev. Dyn. 209:353–366.
   PubMedGoogle Scholar
• Yang, C. C., O. I. Ornatsky, J. C. McDermott, T. F. Cruz, and C. A. Prody. 1998. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res. 26:4771-4777.
   PubMedGoogle Scholar
• Youn, H. D., L. Sun, R. Prywes, and J. O. Liu. 1999. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 286:790–793.
   PubMed Web of Science ®Google Scholar
• Yun, K., and B. Wold. 1996. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8:877–889.
   PubMed Web of Science ®Google Scholar